On August 6, Centrus rose 8.72% in pre-market trading, trading at $203.0/share, with turnover of $2.3583 million. The surge was driven by a combination of a massive Q2 earnings beat and a newly announced supply agreement with X-Energy.

Centrus reported Q2 adjusted EPS of $1.77, exceeding the analyst consensus estimate of $0.77 by approximately 130%. Revenue came in at $176.1 million, beating the $148.764 million estimate and representing significant sequential acceleration from Q1 sales of $76.7 million. Additionally, the company announced a low-enriched uranium and high-assay low-enriched uranium supply agreement with X-Energy, further reinforcing its commercial pipeline.

The results build on a series of major contract wins this year, including a $1.07 billion task order from the U.S. Department of Energy for HALEU production capacity deployment, a partnership with Palantir for AI-driven enrichment expansion, and multiple HALEU supply agreements with Oklo for advanced reactor fuel. These developments position Centrus as a central player in the domestic nuclear fuel supply chain buildout.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)